Abstract
Prospective cross-sectional study was conducted in 54 patients (mean age 46.7 ± 3.7 years) to determine the character of optic nerve axonal degeneration after acute methanol poisoning. Methanol was measured by a gas chromatographic method with flame ionization detection. Formate was measured enzymatically. Measurement of full-field visual evoked potential with monocular checkerboard pattern-reversal stimulation was performed 3–8 and 24–28 months after discharge. The amplitudes of N1P1 and P1N2 components of evoked response were used for analysis of axonal loss. Altogether, 13 of 50 patients (26 %) had abnormal amplitudes at the first examination (including the patients with nonrecordable amplitudes), and 37 patients had normal amplitudes. Mean N1P1/P1N2 amplitudes for right eyes (REs) were 6.30 ± 1.10/8.70 ± 1.50 µV and for left eyes (LEs) were 6.56 ± 1.00/8.30 ± 1.40 µV. The group with abnormal amplitudes had lower arterial pH (p = 0.009), bicarbonate (p = 0.036), higher base deficit (p = 0.005), glucose (p = 0.015), and lactate (p = 0.018). At the second examination, insignificant amplitude changes were registered (REs 6.50 ± 1.10/9.80 ± 1.60 µV, LEs 6.40 ± 1.10/9.30 ± 1.60 µV; both p > 0.05). In 2 of 44 REs (5 %) and in 4 of 45 LEs (9 %) with 2 consecutive examinations the initially normal amplitudes deteriorated to abnormal values. In 3 of 45 patients (7 %) the abnormal amplitudes deteriorated in both eyes indicating the ongoing process of chronic neuronal degeneration. The dynamics of amplitude deterioration correlated with serum lactate (r = 0.533; p < 0.001), glucose (r = 0.462; p = 0.005), and formic acid (r = 0.380; p = 0.046) on admission to hospital. The correlation was present between the magnetic resonance signs of hemorrhagic brain lesions and the amplitude changes (r = −0.535; p < 0.001).
Graphical Abstract
Similar content being viewed by others
References
Bucaretchi F, De Capitani EM, de Madureira PR, Cesconetto DM, Lanaro R, Vieira RJ (2009) Sao Paulo Med J 127:108
Zakharov S, Navratil T, Pelclova D (2013) Basic Clin Pharmacol Toxicol 112:425
Zakharov S, Navratil T, Pelclova D (2013) Psychiatry Res 210:302
Hovda KE, Hunderi OH, Tafjord AB, Dunlop O, Rudberg N, Jacobsen D (2005) J Intern Med 258:181
Paasma R, Hovda KE, Tikkerberi A, Jacobsen D (2007) Clin Toxicol 45:152
Zakharov S, Pelclova D, Urban P, Navratil T, Diblik P, Kuthan P, Hubacek JA, Miovsky M, Klempir J, Vaneckova M, Seidl Z, Pilin A, Fenclova Z, Petrik V, Kotikova K, Nurieva O, Ridzon P, Hovda KE (2014) Clin Toxicol 52:1013
Vaneckova M, Zakharov S, Klempir J, Ruzicka E, Bezdicek O, Liskova I, Diblik P, Miovsky M, Hubacek JA, Urban P, Ridzon P, Pelclova D, Burgetova A, Masek M, Seidl Z (2014) Cesk Slov Neurol N 77:235
Zakharov S, Pelclova D, Diblik P, Urban P, Kuthan P, Nurieva O, Kotikova K, Navratil T, Komarc M, Seidl Z, Vaneckova M, Hubacek JA, Bezdicek O, Klempir J, Yurchenko M, Ruzicka E, Miovsky M, Janikova B, Hovda KE (2015) Clin Toxicol. doi:10.3109/15563650.2015.1086488
Paasma R, Hovda KE, Jacobsen D (2009) BMC Clin Pharmacol 9:5
Liesivuori J, Savolainen H (1991) Pharmacol Toxicol 69:157
Zakharov S, Kurcova I, Navratil T, Salek T, Komarc M, Pelclova D (2015) Basic Clin Pharmacol Toxicol 116:445
Barceloux DG, Bond GR, Krenzelok EP, Cooper H, Vale JA (2002) J Toxicol-Clin Toxicol 40:415
Sharpe JA, Hostovsky M, Bilbao JM, Rewcastle NB (1982) Neurology 32:1093
Carelli V, Ross-Cisneros FN, Sadun AA (2004) Prog Retin Eye Res 23:53
Megarbane B, Borron SW, Baud FJ (2005) Intensiv Care Med 31:189
Zakharov S, Nurieva O, Navratil T, Diblik P, Kuthan P, Pelclova D (2014) J Appl Biomed 12:309
Roberts DM, Yates C, Megarbane B, Winchester JF, Maclaren R, Gosselin S, Nolin TD, Lavergne V, Hoffman RS, Ghannoum M, Treatments E (2015) Crit Care Med 43:461
Zakharov S, Pelclova D, Navratil T, Belacek J, Komarc M, Eddleston M, Hovda KE (2015) Clin Toxicol 53:797
Zakharov S, Navratil T, Pelclova D (2014) Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 158:641
Paasma R, Hovda KE, Hassanian-Moghaddam H, Brahmi N, Afshari R, Sandvik L, Jacobsen D (2012) Clin Toxicol 50:823
Zakharov S, Navratil T, Pelclova D (2015) Monatsh Chem 146:787
Desai T, Sudhalkar A, Vyas U, Khamar B (2013) JAMA Ophthalmol 131:358
Sanaei-Zadeh H, Zamani N, Shadnia S (2011) Clin Toxicol 49:102
Fahle M, Bach M (2006) Origin of the visual evoked potentials. In: Heckenlively JR, Arden GB (eds) Principles and practice of clinical electrophysiology of vision. The MIT Press, Cambridge, p 207
Klistorner A, Arvind H, Nguyen T, Garrick R, Paine M, Graham S, O’Day J, Grigg J, Billson F, Yiannikas C (2008) Ann Neurol 61:325
Hantson P, de Tourtchaninoff M, Simoens G, Mahieu P, Boschi A, Beguin C, Guerit JM (1999) Crit Care Med 27:2707
Kornek B, Storch MK, Weissert R, Wallstroem E, Stefferl A, Olsson T, Linington C, Schmidbauer M, Lassmann H (2000) Am J Pathol 157:267
Costello FE, Klistorner A, Kardon R (2011) Ophthal Surg Lasers Imag 42(Suppl):S28
Yau GSK, Lee JWY, Lau PPK, Tam VTY, Wong WWY, Yuen CYF (2013) Sci World J. doi:10.1155/2013/694613 Article 694613
Costello F, Hodge W, Pan YI, Eggenberger E, Coupland S, Kardon RH (2008) Mult Scler J 14:893
Klistorner A, Graham S, Fraser C, Garrick R, Nguyen T, Paine M, O’Day J, Grigg J, Arvind H, Billson FA (2007) Invest Ophthalmol Vis Sci 48:4549
Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM (2001) Brain 124:1813
Sanaei-Zadeh H, Esfeh SK, Zamani N, Jamshidi F, Shadnia S (2011) J Med Toxicol 7:189
Klistorner A, Arvind H, Garrick R, Graham SL, Paine M, Yiannikas C (2010) Invest Ophthalmol Vis Sci 51:2770
Banasiak KJ, Xia Y, Haddad GG (2000) Prog Neurobiol 62:215
Misra UK, Kalita J, Das A (2003) Electromyogr Clin Neurophysiol 43:57
Fei GQ, Zhong C, Jin L, Wang J, Zhang Y, Zheng X, Zhang Y, Hong Z (2008) AJNR Am J Neuroradiol 29:164
Yeh WY, Lian LM, Chang A, Cheng CK (2013) J Formos Med Assoc 112:165
Fernandez M, Giuliani A, Pirondi S, D’Intino G, Giardino L, Aloe L, Levi-Montalcini R, Calza L (2004) Proc Natl Acad Sci USA 101:16363
Veselinovic D, Jovanovic M (2005) Acta Fac Med NAISS 22:145
Grzybowski A, Zulsdorff M, Wilhelm H, Tonagel F (2015) Acta Ophthalmol (Copenh) 93:402
Love S (2006) J Clin Pathol 59:1151
Zakharov S, Navratil T, Salek T, Kurcova I, Pelclova D (2015) Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. doi:10.5507/bp.2015.008
Zakharov S, Pelclova D, Navratil T, Belacek J, Kurcova I, Komzak O, Salek T, Latta J, Turek R, Bocek R, Kucera C, Hubacek JA, Fenclova Z, Petrik V, Cermak M, Hovda KE (2014) Kidney Int 86:199
Mehraban K, Gmeiner G, Urban E, Gärtner P, Eppacher S, Noe C (2014) Monatsh Chem 145:1631
Laila A (2013) Monatsh Chem 144:307
Aabakken L, Johansen KS, Rydningen EB, Bredesen JE, Ovrebo S, Jacobsen D (1994) Hum Exp Toxicol 13:131
Acknowledgments
This work was supported with the Project of the Ministry of Health of the Czech Republic 9/15/NAP, the Projects of the Charles University in Prague PRVOUK—P25/1LF/2, P26/1LF/2, and P28/1LF/6, and EU Project “Material—technical Research Base for the Diagnostics and Treatment of Environmentally caused and Oncological Disorders and their Risks, in the General University Hospital in Prague” (reg. No. CZ.2.16/3.1.00/24.12).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics
The study was approved by the General University Hospital Ethics Committee in Prague, Czech Republic. Informed consent was obtained from the participants of the study. The study adhered to the tenets of the Declaration of Helsinki.
Rights and permissions
About this article
Cite this article
Zakharov, S., Nurieva, O., Kotikova, K. et al. Factors predicting optic nerve axonal degeneration after methanol-induced acute optic neuropathy: a 2-year prospective study in 54 patients. Monatsh Chem 147, 251–261 (2016). https://doi.org/10.1007/s00706-015-1581-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00706-015-1581-x